ADMA Biologics is a biopharmaceutical company that develops, manufactures, and markets plasma-derived immunoglobulin therapies for immune-deficient and infection-prone patients.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Paul Tudor Jones / Tudor | 61 | New buy | 147,376 | $1,478,181 | 0.0% |
| Bridgewater | 55 | Added +143% | 975,642 | $9,785,689 | 0.0% |
| Terry Smith / Fundsmith | 66 | Holds (flat) | 1,649,493 | $16,544,415 | 0.1% |
| Stanley Druckenmiller / Duquesne | 91 | Trimmed -21% | 2,212,810 | $22,194 | 0.5% |
| Steve Cohen / Point72 | 75 | Trimmed -68% | 161,797 | $1,622,824 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-09-22 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-08-22 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $50,001 - $100,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $50.001 - $100,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.